Resistant Starch for Health & Longevity

Created on 11/05/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5.5 – Audit

Resistant starch, a dietary starch in green bananas, beans, cooled cooked rice or potatoes and inexpensive powders, escapes digestion, feeds gut bacteria and is used to improve blood sugar control. Replacing ordinary starch, it most consistently lowers post-meal blood sugar. Daily use brings small, inconsistent fasting blood sugar and cholesterol gains, clearest with insulin resistance or excess weight. Main drawbacks: gas, bloating and food poisoning from cooked starch left warm. (Full Review)

Protocol

Supplemental RS2, trial doses
15–30 g/day
High-amylose maize RS2; 40 g/day also tested; 45 g/day showed no glycemic benefit
Food-first approach
Cooked-then-refrigerated starches
Potatoes, rice and pasta, plus green bananas and legumes
Starch-substitution approach
Resistant starch at least 14% of total starch
Replacing digestible starch in a meal; the condition of the EU claim
Time to effect
Post-meal glucose
First meal
When resistant starch replaces digestible starch
Fasting glucose and insulin
8 weeks or more
Clearest at about 28 g/day or more
LDL cholesterol
Beyond 4 weeks
Small reduction likely with continued intake

Benefits

Contraindications
  • Known allergy to the source plant (maize, potato, banana or cassava)
  • Bowel obstruction or severe stricturing bowel disease (e.g., in Crohn's disease)
  • Active, untreated SIBO
Key Interactions
Theoretical (inferred from mechanism)
  • Insulin and sulfonylureas (e.g., glipizide, glimepiride): risk of low blood glucose
  • Alpha-glucosidase inhibitors (e.g., acarbose, miglitol): added flatulence and bloating
  • Metformin and GLP-1 receptor agonists (e.g., semaglutide, tirzepatide): additive gastrointestinal side effects
  • Antibiotics (e.g., amoxicillin, ciprofloxacin): reduced fermentation and benefit for weeks
  • Levothyroxine: reduced absorption
  • Fermentable fiber supplements and prebiotics (e.g., inulin, psyllium) and OTC lactulose: added gas and bloating
  • Glucose-lowering supplements (e.g., berberine, cinnamon extract): additive post-meal glucose lowering, mainly relevant with glucose-lowering drugs

Risk & Side Effects

  • High:
  • Medium: Flatulence and bloating
  • Low: Food poisoning from cooled starchy foods
  • Speculative: Higher TMAO levels; allergic reactions to source plants

Monitoring

Marker Target Why
Fasting glucose 70–99 mg/dL Small fall with sustained intake
Fasting insulin / HOMA-IR Fasting insulin 2.6–24.9 µIU/mL; HOMA-IR: no established target, track change from own baseline Insulin resistance may fall
HbA1c 4.0–5.6% At most a slight fall
LDL cholesterol No established target; track change from own baseline Small fall expected
ALT 7–56 U/L May fall in people with fatty liver
Body weight and waist circumference No established target; track change from own baseline Modest fall in some trials
Self-monitored glucose (people on insulin or sulfonylureas) 70 mg/dL or higher Safety check for low blood glucose

Cadence: Baseline panel before starting; daily glucose checks for the first 2 weeks on insulin or sulfonylureas; weekly weight and waist; fasting glucose, insulin and lipids at 8–12 weeks, then every 6–12 months

Qualitative Assessment

  • Gas and bloating: should settle within weeks
  • Stool form: Bristol Stool Form Scale
  • Hunger and fullness after meals
  • Post-meal energy steadiness